The Dual Roles of NRF2 in Cancer

被引:561
作者
Menegon, Silvia [1 ]
Columbano, Amedeo [2 ]
Giordano, Silvia [1 ]
机构
[1] Univ Torino, Dept Oncol, Candiolo Canc Inst FPO, IRCCS, Str Prov 142, I-10060 Turin, Italy
[2] Univ Cagliari, Dept Biomed Sci, Via Porcell 4, I-09124 Cagliari, Italy
关键词
TRANSCRIPTION FACTOR NRF2; CELL DEFENSE PATHWAY; HUMAN LUNG-CANCER; ANTIOXIDANT RESPONSE; KEAP1; GENE; HEPATOCELLULAR-CARCINOMA; OXIDATIVE STRESS; PROTEASOMAL DEGRADATION; NEGATIVE REGULATION; CYSTEINE RESIDUES;
D O I
10.1016/j.molmed.2016.05.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NRF2 has been traditionally considered as a tumor suppressor because its cytoprotective functions are deemed to be the main cellular defense mechanism against exogenous and endogenous insults, including xenobiotics and oxidative stress. However, several recent studies demonstrate that hyperactivation of the NRF2 pathway creates an environment that favors the survival of normal as well as malignant cells, protecting them against oxidative stress, chemotherapeutic agents, and radiotherapy. In a rapidly adva(n)cing field, this review summarizes some of the known mechanisms by which NRF2 can exert its oncogenic functions, and describes the current status of NRF2 inhibitors, providing a clear rationale for the consideration of NRF2 as a powerful putative therapeutic target in cancer treatment.
引用
收藏
页码:578 / 593
页数:16
相关论文
共 109 条
[1]   Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling [J].
Adam, Julie ;
Hatipoglu, Emine ;
O'Flaherty, Linda ;
Ternette, Nicola ;
Sahgal, Natasha ;
Lockstone, Helen ;
Baban, Dilair ;
Nye, Emma ;
Stamp, Gordon W. ;
Wolhuter, Kathryn ;
Stevens, Marcus ;
Fischer, Roman ;
Carmeliet, Peter ;
Maxwell, Patrick H. ;
Pugh, Chris W. ;
Frizzell, Norma ;
Soga, Tomoyoshi ;
Kessler, Benedikt M. ;
El-Bahrawy, Mona ;
Ratcliffe, Peter J. ;
Pollard, Patrick J. .
CANCER CELL, 2011, 20 (04) :524-537
[2]  
[Anonymous], ONCOTARGET
[3]   The cytoprotective role of the Keap1-Nrf2 pathway [J].
Baird, Liam ;
Dinkova-Kostova, Albena T. .
ARCHIVES OF TOXICOLOGY, 2011, 85 (04) :241-272
[4]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[5]   The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation [J].
Bryan, Holly K. ;
Olayanju, Adedamola ;
Goldring, Christopher E. ;
Park, B. Kevin .
BIOCHEMICAL PHARMACOLOGY, 2013, 85 (06) :705-717
[6]   NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development [J].
Chan, KM ;
Lu, RH ;
Chang, JC ;
Kan, YW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13943-13948
[7]   Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism [J].
Chartoumpekis, Dionysios V. ;
Wakabayashi, Nobunao ;
Kensler, Thomas W. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2015, 43 :639-644
[8]   Mechanisms of Drug Action: The Potential of Dimethylfumarate for the Treatment of Neoplasms [J].
Chen, Andrea Federico ;
Kirsner, Robert S. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (06) :1181-1181
[9]   Direct Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response [J].
Chen, Weimin ;
Sun, Zheng ;
Wang, Xiao-Jun ;
Jiang, Tao ;
Huang, Zheping ;
Fang, Deyu ;
Zhang, Donna D. .
MOLECULAR CELL, 2009, 34 (06) :663-673
[10]   The intricacies of p21 phosphorylation - Protein/protein interactions, subcellular localization and stability [J].
Child, Emma S. ;
Mann, David J. .
CELL CYCLE, 2006, 5 (12) :1313-1319